Pfizer-BioNTech COVID-19 vaccine is associated with lower viral load in breakthrough infections – News-Medical.Net

Several vaccines have been rapidly developed to help control the COVID-19 pandemic, including the BNT162b2 vaccine (Pfizer/BioNTech). This severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine has been shown in both clinical trials and in…

Click here to view the original article.